Bioceres Crop Solutions CorpBIOX
Price$0.35

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $335.1M-27.9% YoYTTM through 31 Dec 2025
Net Income -$58.8M-907.3% YoYTTM through 31 Dec 2025
Free Cash Flow $44.3MTTM through 31 Dec 2025

Margins

Current
Gross Margin32.0%
Operating Margin-10.9%
Net Margin-17.6%

Returns

-76.5%ROE
-9.8%ROA

Balance Sheet Health

Debt / Equity3.38x
Current Ratio0.90x
Net Debt$214M
Cash & Equivalents$11.1M

Quality Metrics

Piotroski F-Score2 / 9
FCF Margin13.2%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $335.1M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-0.93

Dividend

No dividend

Capital Allocation

Capex Intensity1.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.